Validation pour Ingenuity084

vers la météo de la validation par utilisateur

Ingenuity084

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 92 - PMID ?

Dyslipidemia in humans is associated with mutant SP NODE protein ( L162V ) .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                +---------COMP:V_PASS-N(with)--------+               
                                |             +-----MOD_ATT:N-ADJ----+               
                                |             |      +-MOD_ATT:N-ADJ-+               
       +------SUBJ:V_PASS-N-----+             |      |       +MOD_ATT+--APPOS-+      
       |                        |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
SUBJ:V_PASS-N (associate,Dyslipidemia)
COMP:V_PASS-N(with) (associate,protein)
MOD_ATT:N-ADJ (protein,mutant)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,L162V)

Analyse 1

                    +----------------SUBJ:V-N----------------+                       
                    |           +-COMP:V_PASS-N(with)+       |                       
       +-MOD_ATT:N-N+SUBJ:V_PASS+             +MOD_AT+       +OBJ:V-N+--APPOS-+      
       |            |           |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,__SP__)
MOD_ATT:N-ADJ (__SP__,mutant)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,protein)
APPOS (protein,L162V)

Analyse 2

                                +-----------COMP:V-N(with)-----------+               
                                |             +-----MOD_ATT:N-ADJ----+               
                                |             |      +-MOD_ATT:N-ADJ-+               
       +-MOD_ATT:N-N+--SUBJ:V-N-+             |      |       +MOD_ATT+--APPOS-+      
       |            |           |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,protein)
MOD_ATT:N-ADJ (protein,mutant)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,L162V)

Analyse 3

                    +----------------SUBJ:V-N----------------+                       
                    +---------COMP:N-N(with)---------+       |                       
       +-MOD_ATT:N-N+SUBJ:V_PASS+             +MOD_AT+       +OBJ:V-N+--APPOS-+      
       |            |           |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
COMP:N-N(with) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
MOD_ATT:N-ADJ (__SP__,mutant)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,protein)
APPOS (protein,L162V)

Analyse 4

                         +------------------SUBJ:V-N-----------------+               
                         |      +------------MOD_ATT:N-ADJ-----------+               
                         |      |             +-----MOD_ATT:N-ADJ----+               
                         |      |             |      +-MOD_ATT:N-ADJ-+               
                         |      |             |      |       +MOD_ATT+--APPOS-+      
                         |      |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
SUBJ:V-N (be,protein)
MOD_ATT:N-ADJ (protein,associate)
MOD_ATT:N-ADJ (protein,mutant)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,L162V)

Analyse 5

                                        +-----------OBJ:V-N----------+               
                                +-COMP:V_PASS-N(with)+               |               
       +------SUBJ:V_PASS-N-----+       |     +MOD_AT+       +MOD_ATT+--APPOS-+      
       |                        |       |     |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
SUBJ:V_PASS-N (associate,Dyslipidemia)
COMP:V_PASS-N(with) (associate,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,L162V)

Analyse 6

                                +-----COMP:V_PASS-N(with)----+                       
                                |       +-----------OBJ:V-N----------+               
                                |       |     +-MOD_ATT:N-ADJ+       |               
       +------SUBJ:V_PASS-N-----+       |     |      +MOD_ATT+       +--APPOS-+      
       |                        |       |     |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
SUBJ:V_PASS-N (associate,Dyslipidemia)
COMP:V_PASS-N(with) (associate,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,L162V)

Analyse 7

                                        +-----------OBJ:V-N----------+               
                                +---COMP:V-N(with)---+               |               
       +-MOD_ATT:N-N+--SUBJ:V-N-+       |     +MOD_AT+       +MOD_ATT+--APPOS-+      
       |            |           |       |     |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,L162V)

Analyse 8

                                +---------------OBJ:V-N--------------+               
                                +---COMP:V-N(with)---+               |               
       +-MOD_ATT:N-N+--SUBJ:V-N-+             +MOD_AT+       +MOD_ATT+--APPOS-+      
       |            |           |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,__SP__)
OBJ:V-N (associate,protein)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,L162V)

Analyse 9

                                +-------COMP:V-N(with)-------+                       
                                |       +-----------OBJ:V-N----------+               
                                |       |     +-MOD_ATT:N-ADJ+       |               
       +-MOD_ATT:N-N+--SUBJ:V-N-+       |     |      +MOD_ATT+       +--APPOS-+      
       |            |           |       |     |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,L162V)

Analyse 10

                                +---------------OBJ:V-N--------------+               
                                +-------COMP:V-N(with)-------+       |               
                                |             +-MOD_ATT:N-ADJ+       |               
       +-MOD_ATT:N-N+--SUBJ:V-N-+             |      +MOD_ATT+       +--APPOS-+      
       |            |           |             |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,__NODE__)
OBJ:V-N (associate,protein)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,L162V)

Analyse 11

                                +---------------OBJ:V-N--------------+               
                                +---COMP:V-N(with)---+               |               
       +-MOD_ATT:N-N+--SUBJ:V-N-+             +MOD_AT+               +--APPOS-+      
       |            |           |             |      |               |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,__SP__)
OBJ:V-N (associate,protein)
MOD_ATT:N-ADJ (__SP__,mutant)
APPOS (protein,L162V)

Analyse 12

                                +---------------OBJ:V-N--------------+               
                                +---COMP:V-N(with)---+               |               
                                |       +-------OBJ:V-N------+       |               
       +-MOD_ATT:N-N+--SUBJ:V-N-+       |     +MOD_AT+       |       +--APPOS-+      
       |            |           |       |     |      |       |       |        |      
 Dyslipidemia in humans is associated with mutant __SP__ __NODE__ protein ( L162V ) .
MOD_ATT:N-N (human,Dyslipidemia)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,__SP__)
OBJ:V-N (associate,protein)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (__SP__,mutant)
APPOS (protein,L162V)